Effects of blockade of the renin-angiotensin system on tissue factor and plasminogen activator inhibitor-1 synthesis in human cultured monocytes

Journal of Hypertension

Volumn 19, Issue 4, 2001, Pages 775-783

  Nagata, Kenji ^a,b   Ishibashi, Toshiyuki ^a,b   Sakamoto, Takayuki ^a,b   Nakazato, Kazuhiko ^a,b   Seino, Yoshitane ^a,b   Yokoyama, Keiko ^a,b   Ohkawara, Hiroshi ^a,b   Teramoto, Tamio ^a,b   Maruyama, Yukio ^a,b  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

Author keywords

Angiotensin II; Angiotensin IV; Bradykinin B2 receptor antagonist; Monocytes; Plasminogen activator inhibitor 1; Tissue factor; Tumour necrosis factor

Indexed keywords

ANGIOTENSIN; BRADYKININ B2 RECEPTOR ANTAGONIST; CANDESARTAN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ICATIBANT; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MONOCYTE; NORMAL HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0035068063     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200104000-00015     Document Type: Article

References (52)

1. The pathogenesis of atherosclerosis: A perspective for the 1990s
2. Molecular bases of the acute coronary syndromes
3. Atherosclerosis: An inflammatory disease
4. Granulocyte-macrophage colony-stimulating factor prevents the progression of atherosclerosis via changes in the cellular and extracellular composition of atherosclerotic lesions in WHHL rabbits
5. Expression of very low density lipoprotein receptor mRNA in rabbit atherosclerotic lesions
6. Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease
7. Upregulation of angiotensin-converting enzyme during the healing process after injury at the site of percutaneous transluminal coronary angioplasty in humans
8. Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: Potential implications for inflammation and plaque instability
9. Evidence that macrophages in atherosclerotic lesions contain angiotensin II
10. Modulation of angiotensin II type 1 receptor mRNA expression in human blood cells: Comparison of platelets and mononuclear leukocytes
11. Upregulation of renin-angiotensin system during differentiation of monocytes to macrophages
12. Release of active tissue factor by human arterial smooth muscle cells
13. The pathogenesis of coronary artery disease and the acute coronary syndromes
14. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology
15. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes
16. Macrophages, smooth muscle cells, and tissue factor in unstable angina: Implications for cell-mediated thrombogenicity in acute coronary syndromes
17. Tissue-factor antigen and activity in human coronary atherosclerotic plaques
18. Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina
19. Increased tissue factor production in circulating monocytes from patients with acute myocardial infarction: Implication for elevated thrombogenicity
20. Atheromatous plaque macrophages produce plasminogen activator inhibitor type-1 and stimulate its production by endothelial cells and vascular smooth muscle cells
21. Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: A potential factor predisposing to thrombosis and its persistence
22. 2+ mobilization and protein kinase C activation
23. Angiotensin II increases plasminogen activator inhibitor-1 and tissue factor mRNA expression without changing that of tissue type plasminogen activator or tissue factor pathway inhibitor in cultured rat aortic endothelial cells
24. AT(1) receptor agonistic antibodies from preeclamptic cause vascular cells to express tissue factor
25. Functional activities of receptors for tumor necrosis factor-α on human vascular endothelial cells
26. Mechanism of the tumor necrosis factor α-mediated induction of endothelial tissue factor
27. Regulation of the tissue factor gene in human monocytic cells: Role of AP-1, NF-κB/Rel, and Sp1 proteins in uninduced and lipopolysaccharide-induced expression
28. Activation of human peripheral monocytes by angiotensin II
29. Angiotensin-converting enzyme inhibitors suppress synthesis of tumour necrosis factor and interleukin 1 by human peripheral blood mononuclear cells
30. Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV
31. Agonist-dependent AT(4) receptor internalization in bovine aortic endothelial cells
32. Angiotensin IV receptor-mediated activation of lung endothelial NOS is associated with vasorelaxation
33. The effects of angiotensin metabolites on the regulation of coagulation and fibrinolysis in cultured rat aortic endothelial cells
34. Proteases in normal and diseased human skeletal muscle: A preliminary histochemical survey
35. Peptidases in human bronchoalveolar lining fluid, macrophages, and epithelial cells: Dipeptidyl (amino)peptidase IV, aminopeptidase N, and dipeptidyl (carboxy) peptidase (angiotensin-converting enzyme)
36. + cells
37. Expression of very low density lipoprotein receptor mRNA in circulating human monocytes: Its upregulation by hypoxia
38. Interleukin-1β and interleukin-6 increase levels of apolipoprotein B mRNA and decrease accumulation of its protein in culture medium of HepG2 cells
39. Expression of cytokine and adhesion molecule mRNA in atherectomy specimens from patients with coronary artery disease
40. An inhibitory monoclonal antibody against human tissue factor
41. Age dependence of tissue plasminogen activator concentrations in plasma, as studied by an improved enzyme-linked immunosorvent assay
42. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
43. A sensitive radio-immunoassay for the determination of plasma angiotensin II in human subjects
44. Angiotensinases restrict locally generated angiotensin II to the blood vessel wall
45. The structural biology of expression and function of tissue factor
46. Protein and messenger RNA levels of plasminogen activators and inhibitors analyzed in 22 human tumor cell lines
47. Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells: A potential link between the renin-angiotensin system and thrombosis
48. Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans
49. Effects of acute angiotensin type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure
50. Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts
51. Effects of imidapril therapy on endogenous fibrinolysis in patients with recent myocardial infarction
52. Angiotensin-converting enzyme inhibitors downregulate tissue factor synthesis in monocytes